Official Report 248KB pdf
Item 6 is consideration of what would normally be described as the convener's report, which has been formulated as the deputy convener's report in the absence of a convener during the past two weeks.
There are two items in the report. First, members will recall that we have raised issues with the Food Standards Agency Scotland on a number of occasions. We have received a response from the minister and it is for members to decide how to progress the matter.
Will you mention the second item? We can then discuss the issues.
Okay. The second item relates to the biofuels directive. The committee has a responsibility to check whether European legislation is correctly transposed by the Scottish Executive. We also consider whether such legislation should be transposed on a UK basis or requires a particularly Scottish response.
On the food supplements issue, the penultimate paragraph of Malcolm Chisholm's letter sums up the situation. I have sympathy with the minister's position. He says:
My concern is that scientists in the UK have in the past reached different conclusions on the matter from scientists elsewhere. As Keith Raffan said, I understand that the minister does not want to become involved in an argument with the scientists whom he employs. However, those scientists went along with the limits that were considered safe in the past, but now we have to listen to scientists from elsewhere. Why are the limits no longer considered safe? Is there evidence that they are not safe? The minister has a role to play in establishing that. Before he takes a view on the matter, he should be convinced that the EFSA is right and that our scientists have been wrong.
We have been round that course already. It is obvious that it is most appropriate to leave it to the scientists to find a conclusive position on the issue. In any case, I suppose that the matter would be better dealt with by the Health Committee.
I have a comment on the dossier preparation costs, which was one of the substantial points that petitioners raised at an early stage. The minister's letter states that discussions at a meeting on 14 October 2003
I will draw the discussion to a close. The first point falls into the category of the difficult matters involving scientific advice. The issue is whether to follow such advice or to question it. I understand Phil Gallie's position. Within the current policy framework, the FSA was established to give an independent imprimatur to issues. The committee's consensus is to accept that and to recognise that, if any new information arises, we can reflect on it in due course.